Delivery Order SPE2DB20D1050-SPE2DB26FH31Y
- Not listed
- The Defense Logistics Agency (DLA) awarded a $12,703.00 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine doses (0.3mL syringes for ages 12 and up). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performs the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for Comirnaty 2024-25 vaccine (12 years and up, 0.3mL syringes) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action under a larger vehicle, this delivery order falls within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and older, 0.3mL syringes) with a ceiling value of approximately $20.2K. This competitively awarded, non-set-aside contract was issued on September 29, 2025, with an ultimate completion date of September 30, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract employs firm fixed-price pricing and represents a delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,175.75 on July 8, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. This firm fixed-price delivery order, which was not set aside for small business, is scheduled for completion by July 9, 2025, with performance at the awardee's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $12,621.20 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12-year-old formulation, 0.3mL syringes) with an ultimate completion date of October 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed from the vendor's location...
- The Defense Logistics Agency awarded a $25,242.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12 years and up, 0.3ml syringes) with an ultimate completion date of October 15, 2025. This non-set-aside award was issued on September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents one of many...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.55 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal...
- AmerisourceBergen Drug Corp was awarded a $3,175.75 delivery order on May 12, 2025, by the Defense Logistics Agency for COMIRNATY 2024-25 (12 years and up) vaccine in 0.3ml syringes, with performance in Conshohocken, Pennsylvania and completion by May 13, 2025. This competitively awarded contract utilized firm fixed pricing with no set-aside designation. As a child delivery order, this award derives from AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,540.60 to AmerisourceBergen Drug Corp for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3 mL syringes. The award was made on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizing firm fixed price delivery order contract terms. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility and was awarded competitively without set-aside designation. This...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB26FH31YDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with a ceiling value of $1,893.18 and an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The place of performance is AmerisourceBergen's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The company's primary IDC vehicle enables it to supply pharmaceutical products and medical supplies to support military healthcare programs globally, including vaccines, medications, and related medical commodities across multiple therapeutic domains. As a prime contractor on this vehicle, AmerisourceBergen competes alongside other vendors under the DLA's Pharmaceutical Prime Vendor Global Program, which strategically distributes supply responsibilities across multiple regional contractors to serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/14/25 |